These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12778057)

  • 21. Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate.
    Amat S; Bougnoux P; Penault-Llorca F; Fétissof F; Curé H; Kwiatkowski F; Achard JL; Body G; Dauplat J; Chollet P
    Br J Cancer; 2003 May; 88(9):1339-45. PubMed ID: 12778058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel.
    Chen YM; Shih JF; Lee CS; Chen MC; Lin WC; Tsai CM; Perng RP
    Lung Cancer; 2003 Feb; 39(2):209-14. PubMed ID: 12581575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: a Gynecologic Oncology Group study.
    Rose PG; Blessing JA; Ball HG; Hoffman J; Warshal D; DeGeest K; Moore DH
    Gynecol Oncol; 2003 Feb; 88(2):130-5. PubMed ID: 12586591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG).
    Cerny T; Kaplan S; Pavlidis N; Schöffski P; Epelbaum R; van Meerbeek J; Wanders J; Franklin HR; Kaye S
    Br J Cancer; 1994 Aug; 70(2):384-7. PubMed ID: 7914429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial.
    Sarris AH; Hagemeister F; Romaguera J; Rodriguez MA; McLaughlin P; Tsimberidou AM; Medeiros LJ; Samuels B; Pate O; Oholendt M; Kantarjian H; Burge C; Cabanillas F
    Ann Oncol; 2000 Jan; 11(1):69-72. PubMed ID: 10690390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.
    Fossella FV; Lee JS; Shin DM; Calayag M; Huber M; Perez-Soler R; Murphy WK; Lippman S; Benner S; Glisson B
    J Clin Oncol; 1995 Mar; 13(3):645-51. PubMed ID: 7884425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC Early Clinical Trials Group.
    Aamdal S; Wolff I; Kaplan S; Paridaens R; Kerger J; Schachter J; Wanders J; Franklin HR; Verweij J
    Eur J Cancer; 1994; 30A(8):1061-4. PubMed ID: 7654429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New antitumor drugs for non-Hodgkin's lymphoma].
    Ohnishi K; Ohno R
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2223-8. PubMed ID: 9881079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Docetaxel as neoadjuvant therapy for radically treatable stage III non-small-cell lung cancer: a multinational randomised phase III study.
    Mattson KV; Abratt RP; ten Velde G; Krofta K
    Ann Oncol; 2003 Jan; 14(1):116-22. PubMed ID: 12488303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
    Fossella FV; DeVore R; Kerr RN; Crawford J; Natale RR; Dunphy F; Kalman L; Miller V; Lee JS; Moore M; Gandara D; Karp D; Vokes E; Kris M; Kim Y; Gamza F; Hammershaimb L
    J Clin Oncol; 2000 Jun; 18(12):2354-62. PubMed ID: 10856094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II trial of docetaxel (Taxotere) in patients with metastatic melanoma previously untreated with cytotoxic chemotherapy.
    Einzig AI; Schuchter LM; Recio A; Coatsworth S; Rodriquez R; Wiernik PH
    Med Oncol; 1996 Jun; 13(2):111-7. PubMed ID: 9013474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study.
    Papakostas P; Kouroussis C; Androulakis N; Samelis G; Aravantinos G; Kalbakis K; Sarra E; Souglakos J; Kakolyris S; Georgoulias V
    Eur J Cancer; 2001 Oct; 37(15):1833-8. PubMed ID: 11576836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II study of docetaxel alternating with cisplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer.
    Mattson K; Vansteenkiste J; Stupp R; Bargetzi M; Saarinen A; Jekunen A; Fillet G; Teixeira M; Gatzemeier U; Olivares R; Soussan-Lazard K; Bérille J
    Anticancer Drugs; 2000 Jan; 11(1):7-13. PubMed ID: 10757557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of efficacy and toxicity of docetaxel (Taxotere) in patients with advanced mammary gland cancer].
    Pawlicki M; Rolski J; Zemełka T; Utych G; Wiczyńska B; Rysz B
    Przegl Lek; 2001; 58(2):59-60. PubMed ID: 11475843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293.
    Einzig AI; Neuberg D; Remick SC; Karp DD; O'Dwyer PJ; Stewart JA; Benson AB
    Med Oncol; 1996 Jun; 13(2):87-93. PubMed ID: 9013471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Docetaxel in the treatment of ovarian cancer.
    Kavanagh JJ
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):73-81. PubMed ID: 12108900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancer.
    Belani CP; Einzig A; Bonomi P; Dobbs T; Capozzoli MJ; Earhart R; Cohen LJ; Luketich JD
    Ann Oncol; 2000 Jun; 11(6):673-8. PubMed ID: 10942054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity and toxicity of docetaxel (Taxotere) in women with previously treated metastatic breast cancer.
    Shapiro JD; Millward MJ; Rischin D; Davison JD; Michael M; Francis PA; Ganju V; Toner GC
    Aust N Z J Med; 1997 Feb; 27(1):40-4. PubMed ID: 9079252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paclitaxel activity for the treatment of non-Hodgkin's lymphoma: final report of a phase II trial.
    Younes A; Ayoub JP; Sarris A; Hagemeister F; North L; Pate O; McLaughlin P; Rodriguez MA; Romaguera J; Kurzrock R; Preti A; Bachier C; Smith T; Cabanillas F
    Br J Haematol; 1997 Feb; 96(2):328-32. PubMed ID: 9029021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer.
    Chevallier B; Fumoleau P; Kerbrat P; Dieras V; Roche H; Krakowski I; Azli N; Bayssas M; Lentz MA; Van Glabbeke M
    J Clin Oncol; 1995 Feb; 13(2):314-22. PubMed ID: 7844592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.